MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia
(2026) In British Journal of Haematology- Abstract
Immune thrombocytopenia (ITP) is a complex autoimmune disorder characterized by accelerated destruction of peripheral platelets and impaired megakaryopoiesis. While the cellular effectors, dysregulated T cells, hyperactive B cells and phagocytic macrophages are well characterized, the upstream epigenetic mechanisms orchestrating this multicellular immune network remain largely elusive. This review explores the hypothesis that microRNAs (miRNAs) may serve as critical architects of immune dysregulation and bone marrow failure in ITP. We evaluate the clinical utility of circulating miRNAs as non-invasive biomarkers for diagnosis, risk stratification and predicting response to steroid and thrombopoietin receptor agonists therapies. Finally,... (More)
Immune thrombocytopenia (ITP) is a complex autoimmune disorder characterized by accelerated destruction of peripheral platelets and impaired megakaryopoiesis. While the cellular effectors, dysregulated T cells, hyperactive B cells and phagocytic macrophages are well characterized, the upstream epigenetic mechanisms orchestrating this multicellular immune network remain largely elusive. This review explores the hypothesis that microRNAs (miRNAs) may serve as critical architects of immune dysregulation and bone marrow failure in ITP. We evaluate the clinical utility of circulating miRNAs as non-invasive biomarkers for diagnosis, risk stratification and predicting response to steroid and thrombopoietin receptor agonists therapies. Finally, we address current translational difficulties, such as data fragmentation and pre-analytical variables. We propose a roadmap for integrating functional validation with multi-omics, utilizing miRNA-based approaches to facilitate and advance precision medicine in ITP.
(Less)
- author
- Liu, Zhenyu
LU
; Rebetz, Johan
LU
; Garabet, Lamya
; Ghanima, Waleed
; Xu, Peipei
; Wadenvik, Hans
; Provan, Drew
; Kapur, Rick
and Semple, John W.
LU
- organization
- publishing date
- 2026
- type
- Contribution to journal
- publication status
- epub
- subject
- keywords
- immunity, immunoregulation, ITP, microRNA (miRNA)
- in
- British Journal of Haematology
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- pmid:41983341
- scopus:105035776754
- ISSN
- 0007-1048
- DOI
- 10.1111/bjh.70485
- language
- English
- LU publication?
- yes
- id
- afc5b94c-b4cb-4e99-b3d2-f54bf73bfece
- date added to LUP
- 2026-06-24 11:56:46
- date last changed
- 2026-09-03 23:57:31
@article{afc5b94c-b4cb-4e99-b3d2-f54bf73bfece,
abstract = {{<p>Immune thrombocytopenia (ITP) is a complex autoimmune disorder characterized by accelerated destruction of peripheral platelets and impaired megakaryopoiesis. While the cellular effectors, dysregulated T cells, hyperactive B cells and phagocytic macrophages are well characterized, the upstream epigenetic mechanisms orchestrating this multicellular immune network remain largely elusive. This review explores the hypothesis that microRNAs (miRNAs) may serve as critical architects of immune dysregulation and bone marrow failure in ITP. We evaluate the clinical utility of circulating miRNAs as non-invasive biomarkers for diagnosis, risk stratification and predicting response to steroid and thrombopoietin receptor agonists therapies. Finally, we address current translational difficulties, such as data fragmentation and pre-analytical variables. We propose a roadmap for integrating functional validation with multi-omics, utilizing miRNA-based approaches to facilitate and advance precision medicine in ITP.</p>}},
author = {{Liu, Zhenyu and Rebetz, Johan and Garabet, Lamya and Ghanima, Waleed and Xu, Peipei and Wadenvik, Hans and Provan, Drew and Kapur, Rick and Semple, John W.}},
issn = {{0007-1048}},
keywords = {{immunity; immunoregulation; ITP; microRNA (miRNA)}},
language = {{eng}},
publisher = {{John Wiley & Sons Inc.}},
series = {{British Journal of Haematology}},
title = {{MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia}},
url = {{http://dx.doi.org/10.1111/bjh.70485}},
doi = {{10.1111/bjh.70485}},
year = {{2026}},
}